Creatinine clearance is independently associated with one year mortality in a primary PCI cohort with cardiogenic shock

References

• Hasdai D, Topol EJ, Califf RM, Berger PB, Holmes DR, Jr. Cardiogenic shock complicating acute coronary syndromes. Lancet 2000; 356: 749–56
   PubMedGoogle Scholar
• Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005; 294: 448–54
   PubMed Web of Science ®Google Scholar
• Bouki KP, Pavlakis G, Papasteriadis E. Management of cardiogenic shock due to acute coronary syndromes. Angiology 2005; 56: 123–30
   PubMed Web of Science ®Google Scholar
• Jeger RV, Harkness SM, Ramanathan K, Buller CE, Pfisterer ME, Sleeper LA, et al. Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry. Eur Heart J. 2006; 27: 664–70
   PubMedGoogle Scholar
• Dzavik V, Sleeper LA, Cocke TP, Moscucci M, Saucedo J, Hosat S, et al. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J. 2003; 24: 828–37
   PubMedGoogle Scholar
• Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, et al. Early revascularization and long-termsurvival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006; 295: 2511–15
   PubMed Web of Science ®Google Scholar
• Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002; 39: 1113–19
   PubMed Web of Science ®Google Scholar
• Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259–64
   PubMed Web of Science ®Google Scholar
• Bertemeu-Gonzalez V, Nunez J, Nunez E, Facila L, Sanchis J, Bodi V, et al. A. Prognostic effect of renal dysfunction after ST-segment elevation myocardial infarction with and without heart failure. Int J Cardiol. 2006; 112: 159–65
   Google Scholar
• McCullough PA, Soman SS, Shah SS, Smith ST, Marks KR, Yee J, et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol. 2000; 36: 679–84
   PubMed Web of Science ®Google Scholar
• Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004; 44: E144–E211
   Google Scholar
• K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–266.
   Google Scholar
• Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003; 139: 137–47
   PubMed Web of Science ®Google Scholar
• Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an international registry. SHOCK Registry Investigators. Circulation 1995; 91: 873–81
   PubMedGoogle Scholar
• Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999; 341: 625–34
   PubMed Web of Science ®Google Scholar
• Mann HJ, Nolan PE, Jr. Update on the management of cardiogenic shock. Curr Opin Crit Care 2006; 12: 431–36
   PubMed Web of Science ®Google Scholar
• Klein LW, Shaw RE, Krone RJ, Brindis RG, Anderson HV, Block PC, et al. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol. 2005; 96: 35–41
   PubMedGoogle Scholar
• Masoudi FA, Plomondon ME, Magid DJ, Sales A, Rumsfeld JS. Renal insufficiency and mortality from acute coronary syndromes. Am Heart J. 2004; 147: 623–29
   Google Scholar
• Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003; 108: 2769–75
   PubMed Web of Science ®Google Scholar
• Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol. 2003; 42: 1535–43
   PubMed Web of Science ®Google Scholar
• Picard MH, Davidoff R, Sleeper LA, Mendes LA, Thompson CR, Dzavik V, et al. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation 2003; 107: 279–84
   PubMed Web of Science ®Google Scholar
• Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 2006; 114: 1572–80
   PubMed Web of Science ®Google Scholar
• Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, et al. Renal insufficiency following contrast media administration trial (REMEDIAL): A randomized comparison of 3 preventive strategies. Circulation 2007; 115: 1211–17
   PubMed Web of Science ®Google Scholar
• Allie DE, Hebert CJ, Walker CM. Multifactorial acute renal failure treated with percutaneous targeted renal therapy (TRT): a case of “dialysis rescue”. J Invasive Cardiol. 2007; 19: E27–E30
   Google Scholar
• Henriques JP, Remmelink M, Baan J, Jr, van der Schaaf RJ, Vis MM, Koch KT, et al. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the impella recover LP 2.5. Am J Cardiol. 2006; 97: 990–92
   PubMed Web of Science ®Google Scholar
• Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005; 26: 1276–83
   PubMed Web of Science ®Google Scholar
• Morley D, Litwak K, Ferber P, Spence P, Dowling R, Meyns B, et al. Hemodynamic effects of parital ventricular support in chronic heart failure: results of simulation validated with in vivo data. J Thorac Cardiovasc Surg. 2007; 133: 21–28
   Google Scholar
• Halbesma N, Kuiken DS, Brantsma AH, Bakker SJ, Wetzels JF, DeZeeuw D, et al. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol. 2006; 17: 2582–90
   PubMed Web of Science ®Google Scholar